https://www.biocentury.com/article/77664/ablynx-nv-management-update
BioCentury - Ablynx NV management update
Ablynx NV, Ghent, Belgium Business: Antibodies, Inflammation Hired: Hennie Hoogenboom as CSO, formerly SVP of discovery at Dyax Corp. ......
ablynxnvmanagementupdate
https://nordiclifescience.org/novo-nordisk-not-intend-make-revised-proposal-ablynx/
Novo Nordisk does not intend to make a revised proposal for Ablynx
Jan 31, 2018 - The company notes the announcement of Sanofi's agreed acquisition of Ablynx and confirms that it will not be making a revised proposal.
novo nordiskdoes notto makeintendrevised